1.	Study of the Effect of Glutamine Supplementation on Chemotherapy Induced Toxicities in Breast Cancer Patients Phase: Phase IV Type: Supportive care Status: Active Age: 18 to 85 Sponsor: Other Protocol IDs: GLU_07, NCT00772824
2.	Trial of Enteral Nutrition Enriched With Eicosapentaenoic Acid (EPA) in Upper Gastrointestinal Cancer Surgery Phase: Phase IV Type: Supportive care Status: Active Age: 18 to 80 Sponsor: Other Protocol IDs: 900/429/1, NCT00790140
3.	Omega-3 Fatty Acids and Chemotherapy-induced Neuropathy and Inflammation in Breast Cancer Phase: Phase IV Type: Biomarker/Laboratory analysis, Supportive care Status: Active Age: 30 to 65 Sponsor: Other Protocol IDs: 88-04-27-9683, NCT01049295
4.	Effectiveness and Safety of Acupuncture for Climacteric Syndrome in Patients With Breast Cancer Phase: Phase IV Type: Supportive care Status: Active Age: 18 to 65 Sponsor: Other Protocol IDs: DGR-2025/2008-Lesi, NCT01275807
5.	The Impact of Preoperative Oral Glutamine Intake on the Immunocompetence and Outcomes of Malnourished Patients Undergoing Major Abdominal Surgery Due to Malignancies Phase: Phase IV Type: Supportive care Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 170/11, NCT01552291
6.	Multi-centre Clinical Trial on Hormone Replacement Treatment in China Phase: Phase IV Type: Prevention Status: Active Age: 40-to 60 Sponsor: Other Protocol IDs: 2008BAI57B04, NCT01698164
7.	Phase II/III Randomized Study of Adjuvant Soy Protein Isolate in Preventing Recurrence in Patients Who Have Undergone Radical Prostatectomy for Stage II Prostate Cancer. Note: The information about this trial has not been updated by the sponsor/principal investigator/lead organization. Cancer.gov cannot verify the accuracy of the information. Phase: Phase III, Phase II Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 40 to 75 Sponsor: NCI Protocol IDs: UIC-2006-0706, 2006-0706, NCT00765479
8.	Smoking Cessation for Veterans With Severe and Persistent Mental Illness Phase: Phase III, Phase II Type: Behavioral study, Prevention Status: Active Age: 18 to 75 Sponsor: Other Protocol IDs: NURA-001-09S, NCT00960375
9.	Effect on the Nutritional and Inflammatory Status of Docosahexaenoic Acid (DHA) and Eicosapentaenoic Acid (EPA)- Containing Supplement in Patients With Advanced Lung Cancer Phase: Phase III, Phase II Type: Supportive care Status: Active Age: 20 to 75 Sponsor: Other Protocol IDs: INCAN/CC/330/09, CA171/CB/558/09, NCT01048970
10.	Compound Herbal Formula (TPE-1) for Leukopenia and Cancer-related Fatigue in Breast Cancer Patients With Radiotherapy Phase: Phase III, Phase II Type: Supportive care Status: Active Age: 18 to 70 Sponsor: Other Protocol IDs: TPE-1-breast Ca, NCT01142479
11.	Acupressure for Persistent Cancer Related Fatigue Phase: Phase III, Phase II Type: Supportive care Status: Active Age: 18 to 75 Sponsor: NCI, Other Protocol IDs: CA151445, R01CA151445, NCT01281904
12.	Cancers Treated With Combination of Antrodia Cinnamomea and Chemotherapy Phase: Phase III, Phase II Type: Supportive care, Treatment Status: Active Age: 18 to 80 Sponsor: Other Protocol IDs: XMRPG890251, NCT01287286
13.	Effect of EPA on Aerobic Performance, Muscle, and Quality of Life in Colorectal Cancer Surgery Patients Phase: Phase III, Phase II Type: Biomarker/Laboratory analysis, Supportive care Status: Active Age: 18 to 85 Sponsor: Other Protocol IDs: 11005, NCT01320319
14.	Diindolylmethane in Treating Patients With Breast Cancer Phase: Phase III, Phase II Type: Biomarker/Laboratory analysis, Diagnostic, Treatment Status: Active Age: 19 and over Sponsor: NCI, Other Protocol IDs: 10-0366-04, NCI-2011-00710, NCT01391689
15.	Additive Homeopathy in Cancer Patients Phase: Phase III, Phase II Type: Supportive care Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 5, NCT01509612
16.	Effect of Omega-3 Supplements on the Prevention of Cachexia in Head and Neck Cancer Treated With Radio(Chemo)Therapy Phase: Phase III, Phase II Type: Biomarker/Laboratory analysis, Supportive care Status: Active Age: 18 and over Sponsor: Other Protocol IDs: NKP_CA_04, NCT01596933
17.	Safety and Efficacy of Oncoxin Plus Surafineb in Hepatocellular Carcinoma Phase: Phase III, Phase II Type: Treatment Status: Active Age: 18 to 70 Sponsor: Other Protocol IDs: OP2, NCT01747642
18.	Vitamin D3 Supplementation for Low-Risk Prostate Cancer: A Randomized Trial Phase: Phase III, Phase II Type: Biomarker/Laboratory analysis, Treatment Status: Approved-not yet active Age: 19 to 90 Sponsor: Other Protocol IDs: CLIN-007-12S, Pro00019745, NCT01759771
19.	Effect of Astragalus-based Formula: Qingshu-Yiqi-Tang on Modulating Immune Alterations in Lung Cancer Patients Phase: Phase III, Phase II Type: Supportive care, Treatment Status: Active Age: 18 to 75 Sponsor: Other Protocol IDs: 97-1967A3, NCT01802021
20.	Evaluation of Effects of Silymarin on Cisplatin Induced Nephrotoxicity in Upper Gastrointestinal Adenocarcinoma Phase: Phase III, Phase II Type: Biomarker/Laboratory analysis, Supportive care, Treatment Status: Approved-not yet active Age: Over 18 to 70 Sponsor: Other Protocol IDs: 91-03-33-18878, NCT01829178
21.	Selenium for Prevention of Adenomatous Colorectal Polyps Phase: Phase III Type: Prevention Status: Active Age: 40 to 80 Sponsor: NCI, Other Protocol IDs: CDR0000353185, P30CA023074, UARIZ-00-0430-01, UARIZ-HSC-00142, P01CA041108, 00-0430-01, NCT00078897
22.	Oral Diindolylmethane (DIM) for the Treatment of Cervical Dysplasia Phase: Phase III Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 9218, NCT00212381
23.	Randomized Placebo-Controlled Trial of Glutamine for Breast Cancer Patients With Peripheral Neuropathy Phase: Phase III Type: Biomarker/Laboratory analysis, Supportive care Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 0309006308, NCT00195013
24.	Effects of Selected Vegetable and Herb Mix (SV) on Advanced Non-Small Cell Lung Cancer Phase: Phase III Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: SV-001 and SV-002, SFC-SV001, SFC-01-0150-0001-02-CM, SFC-01-0150-001, SFC-SV002, NCT00246727
25.	Glutamic Acid in Reducing Nerve Damage Caused by Vincristine in Young Patients Receiving Vincristine for Wilms' Tumor, Rhabdomyosarcoma, Acute Lymphoblastic Leukemia, or Non-Hodgkin's Lymphoma Phase: Phase III Type: Supportive care Status: Active Age: 3 to 20 Sponsor: NCI, Other Protocol IDs: CDR0000463882, SCUSF-0402, HLMCC-0402, ACCL 0731, NCT00369564